U.S. Stem Cell, Inc. Note Agreements

26 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amended and Restated Senior Convertible Note between Bioheart, Inc. and Magna Equities II, LLC (October 1, 2015)
Note Agreements
U.S. Stem Cell, Inc.
Biotechnology
IL
2015
Senior Convertible Note between Bioheart, Inc. and Magna Equities II, LLC dated December 3, 2015
Note Agreements
U.S. Stem Cell, Inc.
Biotechnology
IL
2015
Senior Convertible Note Agreement between Bioheart, Inc. and Magna Equities II, LLC dated October 1, 2015
Note Agreements
U.S. Stem Cell, Inc.
Biotechnology
NY
2015
Senior Convertible Note Agreement between Bioheart, Inc. and Magna Equities II, LLC (October 7, 2014)
Note Agreements
U.S. Stem Cell, Inc.
Biotechnology
NY
2014
Senior Convertible Note Agreement between Bioheart, Inc. and Magna Equities II, LLC (October 7, 2014)
Note Agreements
U.S. Stem Cell, Inc.
Biotechnology
NY
2014
Bioheart, Inc. 8% Unsecured Convertible Note with Greystone Capital Partners (2012)
Note Agreements
U.S. Stem Cell, Inc.
Biotechnology
2012
Bioheart, Inc. 8% Unsecured Convertible Note with Greystone Capital Partners (Subordinated to BlueCrest)
Note Agreements
U.S. Stem Cell, Inc.
Biotechnology
2011
Bioheart, Inc. $35,000 Eight Percent Unsecured Convertible Note with Thalia Woods Management, Inc.
Note Agreements
U.S. Stem Cell, Inc.
Biotechnology
2011
Bioheart, Inc. 8% Unsecured Convertible Note with Greystone Capital Partners (Subordinated to BlueCrest)
Note Agreements
U.S. Stem Cell, Inc.
Biotechnology
2011
Bioheart, Inc. 8% Unsecured Convertible Note with Greystone Capital Partners (Subordinated to BlueCrest)
Note Agreements
U.S. Stem Cell, Inc.
Biotechnology
2011
Bioheart, Inc. 8% Unsecured Convertible Note with Greystone Capital Partners (August 1, 2011)
Note Agreements
U.S. Stem Cell, Inc.
Biotechnology
2011
Bioheart, Inc. $140,380.21 Eight Percent Unsecured Convertible Note to Greystone Capital Partners (July 8, 2011)
Note Agreements
U.S. Stem Cell, Inc.
Biotechnology
2011
Bioheart, Inc. $139,728.82 8% Unsecured Convertible Note to Lotus Funding Group, LLC (June 15, 2011)
Note Agreements
U.S. Stem Cell, Inc.
Biotechnology
2011
Amended and Restated 8% Unsecured Convertible Note between Bioheart, Inc. and Magna Group, LLC (May 16, 2011)
Note Agreements
U.S. Stem Cell, Inc.
Biotechnology
2011
Unsecured Convertible Promissory Note between Bioheart, Inc. and Magna Group, LLC dated May 16, 2011
Note Agreements
U.S. Stem Cell, Inc.
Biotechnology
NY
2011
Notice of Conversion for Convertible Note – Magna Group, LLC and Bioheart, Inc.
Note Agreements
U.S. Stem Cell, Inc.
Biotechnology
2011
Amended and Restated 8% Unsecured Convertible Note between Bioheart, Inc. and Magna Group, LLC
Note Agreements
U.S. Stem Cell, Inc.
Biotechnology
2011
Unsecured Convertible Promissory Note between Bioheart, Inc. and Magna Group, LLC dated January 3, 2011
Note Agreements
U.S. Stem Cell, Inc.
Biotechnology
NY
2011
Promissory Note between Bioheart, Inc. and Seaside National Bank & Trust dated October 25, 2010
Note Agreements
U.S. Stem Cell, Inc.
Biotechnology
FL
2010
Amended and Restated Promissory Note between Bioheart, Inc. and BlueCrest Venture Finance Master Fund Limited (December 31, 2009)
Note Agreements
U.S. Stem Cell, Inc.
Biotechnology
2010
Bioheart, Inc. and Investor Note Purchase Agreement (10% Convertible Promissory Note)
Note Agreements
U.S. Stem Cell, Inc.
Biotechnology
FL
2009
10% Convertible Promissory Note between Bioheart, Inc. and Dana Smith, dated July 23, 2009
Note Agreements
U.S. Stem Cell, Inc.
Biotechnology
FL
2009
10% Convertible Promissory Note between Bioheart, Inc. and Bruce Meyers, Due July 23, 2010
Note Agreements
U.S. Stem Cell, Inc.
Biotechnology
FL
2009
Closing Confirmation of Conversion Election between Bioheart, Inc. and Bruce Meyer & Dana Smith
Note Agreements
U.S. Stem Cell, Inc.
Biotechnology
2009
Amended and Restated Promissory Note between Bioheart, Inc. and BlueCrest Venture Finance Master Fund Limited (April 2, 2009)
Note Agreements
U.S. Stem Cell, Inc.
Biotechnology
2009
Bioheart, Inc. Bridge Financing Promissory Note and Stock Purchase Agreement with Investor
Note Agreements
U.S. Stem Cell, Inc.
Biotechnology
2009